Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands

Johannes J. M. Kwakman*, G. Vink, J. H. Vestjens, L. V. Beerepoot, J. W. de Groot, R. L. Jansen, F. L. Opdam, H. Boot, G. J. Creemers, J. M. van Rooijen, M. Los, A. J. E. Vulink, H. Schut, E. van Meerten, A. Baars, P. Hamberg, E. Kapiteijn, D. W. Sommeijer, C. J. A. Punt, M. Koopman

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)482-489
Number of pages8
JournalInternational Journal of Clinical Oncology
Volume23
Issue number3
DOIs
Publication statusPublished - 1 Jun 2018

Keywords

  • Trifluridine/tipiracil
  • TAS-102
  • Metastatic colorectal cancer
  • Compassionate use
  • Feasibility
  • QUALITY-OF-LIFE
  • THYMIDINE PHOSPHORYLASE
  • PERFORMANCE STATUS
  • ANTITUMOR-ACTIVITY
  • NEUTROPENIA
  • PREDICTOR
  • SURVIVAL
  • EFFICACY
  • TRIAL

Cite this